SPP1 and lung carcinoma: On the other hand, knockdown of SPP1 using siRNAs effectively restored the sensitivity of A549 cells to cisplatin treatment, which suggests that silencing SPP1 could be a viable means to increase the sensitivity of lung cancer to cisplatin treatment.